FedOpsFedOps
Description
Request for Information (RFI) Defense Health Agency (DHA) Enterprise Polysomnography (PSG) System DISCLAIMER: This is NOT a Request for Proposal (RFP) nor a Request for Quotations (RFQ). It is strictly an RFI and should not be construed as a formal solicitation nor an obligation on the part of the Government to acquire any products or services. Neither unsolicited proposals nor any other kinds of offers will be considered in response to this RFI, and no contract will be awarded pursuant to this announcement. The information requested by this RFI will be used within DHA to facilitate decision making and will not be disclosed outside of DHA. Any information provided to the Government is strictly voluntary and will be provided at no cost to the Government. SUBJECT: The Medical Research and Development Contracting Division 2, Defense Health Agency Contracting Activity (DHACA), is seeking information in the form of capabilities statements and availability. This RFI is for fact-finding and planning purposes only. The information will be used in conducting market research to identify qualified, experienced, and interested potential business sources in support of the Government's requirements outlined in Attachment 1, which are subject to change prior to a formal solicitation release. The Government reserves the right to decide whether a small business set-aside is appropriate based on responses to this notice. Contractors are encouraged to inform the Government of any barriers that would prohibit them from competing. Contact with Government personnel, other than those specified in the RFI, by potential offerors or their employees regarding this requirement is not permitted. 3.0 BACKGROUND: The DHA currently faces challenges in effectively diagnosing and managing sleep disorders due to lack of standards and limitations in its PSG capabilities. Specific issues: Standardization: There is not a consistent PSG system across the 22 DHA-managed sleep laboratories. This inconsistency can lead to variations in data acquisition and analysis, potentially impacting diagnosis accuracy. Network Inaccessibility: Existing PSG systems operate in isolated, "off network" environments. This isolation prevents data transfer between facilities and uploads to the enterprise electronic health record (EHR). Data Exchange Obstacles: Due to the lack of network connectivity, sharing PSG data electronically becomes impossible. This hinders: Collaboration between sleep specialists across different facilities. Timely access to patient information for diagnosis and treatment. Potential use of centralized data analysis for research purposes. These limitations significantly hinder DHA's ability to efficiently diagnose and manage sleep disorders such as obstructive sleep apnea, narcolepsy, and idiopathic hypersomnia. Additionally, the lack of an enterprise network accreditation raises potential concerns about data security and compliance. As DHA transitions toward greater standardizatio…
Classification
Place of Performance
Contacts
Attachments (2)